Carrot Health MarketView(R) Customers Dominate 2021 Medicare AEP Performance
ACCESSWIRE
25 May 2021, 23:05 GMT+10
Health plans utilizing Carrot Health data and sales models outperformed the competition during 2021 AEP in overall membership growth and retention rates.
MINNEAPOLIS, MN / ACCESSWIRE / May 25, 2021
/Carrot Health, a leading provider of healthcare solutions powered by consumer and claims data, announced today that health plans utilizing its Carrot MarketView® platform realized a 2021 Medicare annual election period (AEP) growth rate twice that of their competition. This includes average member retention rates of more than 95% across all health plan customers and new member conversion rates 5.2 times higher when Carrot Health predictive modeling was used.
Adcore Announces New Contract With Israel s Largest Department Store Chain
ACCESSWIRE
TORONTO, ON / ACCESSWIRE / May 25, 2021 / Adcore Inc. (the
Company or
Adcore ) (TSX:ADCO) (FSE:ADQ), a leading e-commerce advertising management and automation platform to leverage digital marketing in an effortless and accessible way (
Effortless
Advertising ), is pleased to announce that it has entered into an agreement to provide its digital marketing technologies and services to Hamashbir Lazarchan Department Stores Ltd. (TASE Listed), Israel s largest department store chain. Adcore will provide digital marketing services to the chain s 36 retail locations across Israel and will also support the chain s newly launched E-Commerce site. The contract is valued at CAD$1.5M million.
Wedgemount Announces Grant of Incentive Stock Options
ACCESSWIRE
VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / Wedgemount Resources Corp. (CSE:WDGY) (
Wedgemount or the Company ), a mineral exploration company focused on maximizing shareholder value through the acquisition, discovery and advancement of high-quality copper - gold projects in North America,
has approved the grant of incentive stock options (each, an
Option ) to acquire up to 1,000,000 common shares in the capital of the Company (each a
Common Share ), 800,000 of which were granted to certain directors and officers of the Company. The Options are exercisable for a five year term expiring on May 25, 2026 at a price of $0.45 per Option. The Options are subject to vesting provisions, with 1/4 vesting 3 months from grant date and 1/4 vesting every 3 months thereafter. The Options are subject to Canadian Securities Exchange approval, and approval of the Option plan by Wedgemount s shareholders at the Company s f
Torq Options Andrea Copper Porphyry Project in Chile
ACCESSWIRE
25 May 2021, 21:05 GMT+10
VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / Torq Resources Inc. (TSXV:TORQ)(OTCQX:TRBMF) ( Torq or the Company ) is pleased to announce that it has successfully acquired the option to earn a 100% interest in the Andrea copper porphyry project located in northern Chile, 100 kilometres (km) east of the city of La Serena. The property is located at the western margin of the Miocene aged El Indio belt that hosts the world-class El Indio and Pascua Lama epithermal gold and silver deposits (Barrick Gold Corporation) (Figure 1). This belt was extensively explored for precious metal epithermal deposits in the 1980s - 1990s, but remains highly under-explored for copper porphyry systems.
Avinger Announces Issuance and Allowance of Seven U.S. Patents
ACCESSWIRE
REDWOOD CITY, CA / ACCESSWIRE /
May 25, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the issuance and allowance of seven U.S. patents to date in 2021.
These new U.S. patents include a wide range of claims relating to Avinger s proprietary optical coherence tomography (OCT) intravascular imaging system and its OCT-guided catheters for the treatment of vascular disease. With the addition of these patents and new filings made in 2021, Avinger s intellectual property portfolio now numbers 182 patents and pending applications, including 41 issued and allowed patents in the U.S. and 76 issued and allowed patents outside the U.S. The portfolio has broad applicability in the areas of atherectomy, CTO-crossing and intravascular